News

Sales of Danish drugmaker Novo Nordisk 's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month ...
AN influencer says she’s been trolled for still eating her favourite pizza, smothered in chips, cheese and curry sauce.
With skinny jabs and shrinking waistlines becoming the new normal‭, ‬many fitness conscious are opting for smaller‭, ...
The number of people taking weight-loss injections is exploding. With more and more men going “on the needle”, here’s what ...
As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...
Mr Ratcliffe started on Mounjaro after slowly regaining around 10 stone in weight following a successful Weight Watchers programme a decade before. It had become harder to lose weight as he got older, ...
A WOMAN who has lost 6st using weight loss jabs has warned against one of the hidden side effects. Kelly Kay, from the UK, ...
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo ...
Eli Lilly's weight-loss drug Mounjaro has achieved over Rs 100 crore in sales within four months of its launch in India.
Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage ...
The National Institute for Health and Care Excellence (Nice) said people finishing treatment through the NHS must receive ...